23 June 1994 Dye-enhanced diode laser photocoagulation of choroidal neovascularizations
Author Affiliations +
Proceedings Volume 2126, Ophthalmic Technologies IV; (1994) https://doi.org/10.1117/12.178590
Event: OE/LASE '94, 1994, Los Angeles, CA, United States
Dye-enhanced diode laser photocoagulation, using the dye indocyanine green (ICG), has shown some potential in the treatment of choroidal neovascularizations (CNV). A diode laser system was developed and optimized to emit at the absorption maximum of ICG. In a clinical study at two retinal centers, more than 70 patients, the majority of which had age-related macular degeneration, were treated. Eighteen cases with ill-defined subfoveal CNV were followed an average of 11 months after laser treatment. The results show success in resolving the CNV with an average long-term preservation of visual function equal to or superior to data provided by the Macular Photocoagulation Study for confluent burns of low intensity applied to the CNV. Details of the technique and discussion of the controversies inherent in such a treatment strategy will be presented.
© (1994) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Ulrich Klingbeil, Ulrich Klingbeil, Carmen A. Puliafito, Carmen A. Puliafito, Dan McCarthy, Dan McCarthy, Elias Reichel, Elias Reichel, Joseph Olk, Joseph Olk, Michael L. Lesiecki, Michael L. Lesiecki, } "Dye-enhanced diode laser photocoagulation of choroidal neovascularizations", Proc. SPIE 2126, Ophthalmic Technologies IV, (23 June 1994); doi: 10.1117/12.178590; https://doi.org/10.1117/12.178590

Back to Top